114 related articles for article (PubMed ID: 3473689)
1. Interferon alfa-2b in the treatment of chronic myelogenous leukemia.
Niederle N; Kloke O; Osieka R; Wandl U; Opalka B; Schmidt CG
Semin Oncol; 1987 Jun; 14(2 Suppl 2):29-35. PubMed ID: 3473689
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.
Niederle N; Kloke O; May D; Becher R; Osieka R; Schmidt CG
Invest New Drugs; 1987; 5 Suppl():S19-25. PubMed ID: 3474219
[TBL] [Abstract][Full Text] [Related]
3. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
[TBL] [Abstract][Full Text] [Related]
4. [alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia].
Niederle N; Kloke O; Doberauer C; Becher R; Beelen DW; Schmidt CG
Dtsch Med Wochenschr; 1986 May; 111(20):767-72. PubMed ID: 3516621
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
Bergsagel DE; Haas RH; Messner HA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):29-34. PubMed ID: 3464099
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration.
Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Grignani F
Blood; 1988 Aug; 72(2):642-7. PubMed ID: 3165298
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inveradi D; Bernasconi P; Mancini M; Grignani F; Bernasconi C
Cancer Treat Rev; 1988 Jan; 15 Suppl A():21-6. PubMed ID: 3277708
[No Abstract] [Full Text] [Related]
8. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa-2b in the management of chronic granulocytic leukemia.
Bergsagel DE
Cancer Treat Rev; 1988 Jan; 15 Suppl A():15-20. PubMed ID: 3422593
[No Abstract] [Full Text] [Related]
10. Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients.
Niederle N; Moritz T; Kloke O; Wandl U; May D; Becher R; Franz T; Opalka B; Schmidt CG
Eur J Cancer; 1991; 27 Suppl 4():S7-14. PubMed ID: 1799485
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter study.
Werter M; de Witte R; Janssen J; de Pauw B; Haanen C
Blut; 1988 May; 56(5):209-12. PubMed ID: 3285912
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children.
Ochs J; Abromowitch M; Rudnick S; Murphy SB
J Clin Oncol; 1986 Jun; 4(6):883-7. PubMed ID: 3458876
[TBL] [Abstract][Full Text] [Related]
13. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
Bergsagel DE; Haas RH; Messner HA
Invest New Drugs; 1987; 5 Suppl():S9-17. PubMed ID: 3298136
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of tumor necrosis factor predict unresponsiveness to treatment with interferon alfa-2b in chronic myelogenous leukemia.
Herrmann F; Helfrich SG; Lindemann A; Schleiermacher E; Huber C; Mertelsmann R
J Clin Oncol; 1992 Apr; 10(4):631-4. PubMed ID: 1548526
[TBL] [Abstract][Full Text] [Related]
15. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
[TBL] [Abstract][Full Text] [Related]
16. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
[TBL] [Abstract][Full Text] [Related]
17. [Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)].
Khoroshko ND; Turkina AG; Zakharova AV; Kobzev IuN; Domracheva EV; Tikhonova LIu; Semenova EA; Zhuravlev VS; Sokolova MA; Kuznetsov SV
Ter Arkh; 1999; 71(7):42-7. PubMed ID: 10481867
[TBL] [Abstract][Full Text] [Related]
18. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.
Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H
Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882
[TBL] [Abstract][Full Text] [Related]
19. Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation.
Higano CS; Raskind WH; Singer JW
Acta Haematol; 1993; 89 Suppl 1():8-14. PubMed ID: 8475671
[TBL] [Abstract][Full Text] [Related]
20. Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b.
Seewann HL; Zikulnig R; Gallhofer G; Schmid C
Eur J Cancer; 1991; 27 Suppl 4():S58-62; discussion S62-3. PubMed ID: 1799482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
